Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 23,800 shares, a decline of 67.3% from the May 15th total of 72,800 shares. Based on an average daily volume of 178,400 shares, […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance GLMD stock opened at $0.36 on Friday. Galmed Pharmaceuticals has a 12 month low of $0.26 and a 12 month […]
StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note issued to investors on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $0.36 on Friday. The firm has a market capitalization of $1.83 million, a P/E […]
StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance NASDAQ:GLMD opened at $0.39 on Friday. Galmed Pharmaceuticals has a 52 week low of $0.26 and a 52 week […]
Investment analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of GLMD opened at $0.39 on Friday. The stock has a market capitalization of $1.96 million, a […]